Clincosm LogoSign in Get a demo

vin 2

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Guangxi (Experimental: Experimental: 9-valent Human Papillomavirus

Completed
  • HPV Infections
  • +14 more
  • Experimental: Experimental: 9-valent Human Papillomavirus (Types 6, 11, 16, 18, 31, 33, 45, 52, 58)
  • Active Comparator: GARDASIL ®9
  • Guangxi, China
    Guangxi Zhuang Autonomous Region Center for Disease Control and
May 9, 2022

HPV Infections, Cervical Cancer, Vulvar Cancer Trial in Hangzhou (9-valent HPV vaccine)

Recruiting
  • HPV Infections
  • +14 more
  • 9-valent HPV vaccine
  • Hangzhou, China
    Huakun Lv
Feb 23, 2022

Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Yangchun (4-valent HPV Vaccine, 9-valent HPV Vaccine, GARDASIL®)

Completed
  • Cervical Cancer
  • +13 more
  • 4-valent HPV Vaccine
  • +2 more
  • Yangchun, Guangdong, China
    Yangchun Center For Disease Prevention And Control
Feb 23, 2022

Cervical Cancer, Vulvar Cancer, Vaginal Cancer Trial in Rongan County (9-valent Human Papillomavirus (Types 6, 11, 16,

Recruiting
  • Cervical Cancer
  • +13 more
  • 9-valent Human Papillomavirus (Types 6, 11, 16, 18,31,33,45,52 and 58) Recombinant Vaccine (Hansenula Polymorpha)
  • GARDASIL®
  • Rongan County, Guangxi Zhuang Autonomous Region, China
    Rongan County Center for Disease Control and Prevention
Feb 20, 2022